南京麦澜德医疗科技股份有限公司高级管理人员减持计划时间届满暨减持股份结果公告

Core Viewpoint - The announcement details the results of a share reduction plan by a senior executive of Nanjing Mailland Medical Technology Co., Ltd, indicating that the planned share reduction did not occur within the specified timeframe [1][3]. Group 1: Shareholding Information - Before the reduction plan, the company's Vice President and Board Secretary, Chen Jiangning, held 1,039,261 shares, accounting for 1.0393% of the total share capital [2]. - The shares held by Chen Jiangning were from the company's initial public offering and were released from restrictions on February 19, 2024 [2]. Group 2: Reduction Plan Implementation Results - According to the reduction plan disclosed on August 15, 2025, Chen Jiangning intended to reduce her holdings by up to 259,815 shares, representing no more than 0.26% of the total share capital, due to personal financial needs [3]. - The reduction was to be executed through centralized bidding and block trading, with prices determined by market conditions [3]. - The company received a notification from Chen Jiangning stating that she did not reduce her shareholdings during the period from September 5, 2025, to December 4, 2025, and the reduction plan has now expired [3][5]. Group 3: Compliance and Plan Status - The reduction plan was in compliance with relevant laws and regulations, and the actual reduction situation was consistent with the previously disclosed plan [6]. - The reduction plan did not set a minimum reduction quantity or percentage, and it was confirmed that no shares were sold during the specified period [5][6].